{"name":"Shi Ming","slug":"shi-ming","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Candonilimab","genericName":"Candonilimab","slug":"candonilimab","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Candonilimab","genericName":"Candonilimab","slug":"candonilimab","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE8yYVlPY3QxMGFIUGRxamFfcmVIVVZkTnhlVFJrQWdXOHJkVEtBcXpDRnlsNHU4ZlJaNFpVZmhoVnRlOERrc202TFhvNC1lRm13eDRQcC1mQngxLUU0ZVlfbVhUcWhQLTVDY3c?oc=5","date":"2025-08-13","type":"pipeline","source":"Wiley Online Library","summary":"Nickel‐Catalyzed Cascade C–H Alkynylation/Hydroamination of Free Benzylamines for the Synthesis of Substituted 1H‐Isoindoles Using a Transient Directing Group Strategy - Cai - Chinese Journal of Chemi","headline":"Nickel‐Catalyzed Cascade C–H Alkynylation/Hydroamination of Free Benzylamines for the Synthesis of Substituted 1H‐Isoind","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQaFdKRXdwbzhkTTlIN2xvNjhZTG9ib2JtSTZ2UjhsRmREQmRSamZCck90NTc3WDY1MkdkZ19xWlJxLTdGX1pUdm9vVnJGQlMyOTljZDNSY0pleDJxWTloY0ZoVUprMWgzU0FyUWxoOUVMdEhiZUcyXzBSYnhqcUtwTVZwZ2dkQ195OWowa29fM1lZZjkwbWlReHg0aw?oc=5","date":"2024-07-04","type":"pipeline","source":"KrASIA","summary":"China’s pharmaceutical industry bets big on small nucleic acid drugs in 2024 - KrASIA","headline":"China’s pharmaceutical industry bets big on small nucleic acid drugs in 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPdlpiblhfOTdzbkx0TnJWNGdKM3lySUZMOVJ2d2NTWFJRdDdZeHV2bE50bDlZRFFuM0RBUlJzNUVHMTAtblBzdkw0eHVoWldwTWVZT2llSlpJRnMwM1dlM3p5VkVUdnBBY19tSU5oTjdZaFRXbl9PN1Y3M0g4Mi16Mk5RaHB2LWtlU1ZGSzdMa0g3aWJBNEFJVlF5UlprbkI5bldqekpud3FMa0ZYWXc2N2I2RGtfWTVwWGRFMmtpbV8?oc=5","date":"2022-03-21","type":"pipeline","source":"news.uams.edu","summary":"MD Anderson Oncologist Shi-Ming Tu, M.D., Joins UAMS Winthrop P. Rockefeller Cancer Institute - news.uams.edu","headline":"MD Anderson Oncologist Shi-Ming Tu, M.D., Joins UAMS Winthrop P. Rockefeller Cancer Institute","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}